Alkermes: Supporting Our Patients During COVID-19
Jul 22, 2020 12:00 PM ET
![](/sites/default/files/styles/carousel_2x/public/images/alk_li_1_071420.jpeg)
While the COVID-19 pandemic has created so much uncertainty, we remain committed to supporting people living with substance use disorders and schizophrenia and helping to assure that patients have access to our medicines.